321 related articles for article (PubMed ID: 31754939)
1. Therapeutic potential of quercetin on human breast cancer in different dimensions.
Kasiri N; Rahmati M; Ahmadi L; Eskandari N; Motedayyen H
Inflammopharmacology; 2020 Feb; 28(1):39-62. PubMed ID: 31754939
[TBL] [Abstract][Full Text] [Related]
2. Quercetin: A functional dietary flavonoid with potential chemo-preventive properties in colorectal cancer.
Darband SG; Kaviani M; Yousefi B; Sadighparvar S; Pakdel FG; Attari JA; Mohebbi I; Naderi S; Majidinia M
J Cell Physiol; 2018 Sep; 233(9):6544-6560. PubMed ID: 29663361
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects.
Tang SM; Deng XT; Zhou J; Li QP; Ge XX; Miao L
Biomed Pharmacother; 2020 Jan; 121():109604. PubMed ID: 31733570
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive view on the quercetin impact on bladder cancer: Focusing on oxidative stress, cellular, and molecular mechanisms.
Golmohammadi M; Elmaghraby DA; Ramírez-Coronel AA; Rakhimov N; Mohammed SS; Romero-Parra RM; Jawad MA; Zamanian MY; Soltani A; Taheri N; Kianifar F; Vousooghi N
Fundam Clin Pharmacol; 2023 Oct; 37(5):900-909. PubMed ID: 36960597
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of sodium and potassium quercetin-5'-sulfonates through inhibition of proliferation, induction of apoptosis, and cell cycle arrest in the HT-29 human adenocarcinoma cell line.
Czerwonka A; Maciołek U; Kałafut J; Mendyk E; Kuźniar A; Rzeski W
Bioorg Chem; 2020 Jan; 94():103426. PubMed ID: 31784064
[TBL] [Abstract][Full Text] [Related]
6. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells.
Choi EJ; Bae SM; Ahn WS
Arch Pharm Res; 2008 Oct; 31(10):1281-5. PubMed ID: 18958418
[TBL] [Abstract][Full Text] [Related]
8. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of action of quercetin in cancer: recent advances.
Kashyap D; Mittal S; Sak K; Singhal P; Tuli HS
Tumour Biol; 2016 Oct; 37(10):12927-12939. PubMed ID: 27448306
[TBL] [Abstract][Full Text] [Related]
10. A review on anti-cancer properties of Quercetin in breast cancer.
Ezzati M; Yousefi B; Velaei K; Safa A
Life Sci; 2020 May; 248():117463. PubMed ID: 32097663
[TBL] [Abstract][Full Text] [Related]
11. Rutin, a Quercetin Glycoside, Restores Chemosensitivity in Human Breast Cancer Cells.
Iriti M; Kubina R; Cochis A; Sorrentino R; Varoni EM; Kabała-Dzik A; Azzimonti B; Dziedzic A; Rimondini L; Wojtyczka RD
Phytother Res; 2017 Oct; 31(10):1529-1538. PubMed ID: 28752532
[TBL] [Abstract][Full Text] [Related]
12. Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells.
Lan H; Hong W; Fan P; Qian D; Zhu J; Bai B
Cell Physiol Biochem; 2017; 43(2):553-567. PubMed ID: 28965117
[TBL] [Abstract][Full Text] [Related]
13. Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor-positive breast cancer therapy: An in vitro study.
Xu Z; Zhao D; Zheng X; Huang B; Xia X; Pan X
Environ Toxicol; 2020 Nov; 35(11):1179-1193. PubMed ID: 32530119
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin.
Choi JA; Kim JY; Lee JY; Kang CM; Kwon HJ; Yoo YD; Kim TW; Lee YS; Lee SJ
Int J Oncol; 2001 Oct; 19(4):837-44. PubMed ID: 11562764
[TBL] [Abstract][Full Text] [Related]
15. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells.
Chou CC; Yang JS; Lu HF; Ip SW; Lo C; Wu CC; Lin JP; Tang NY; Chung JG; Chou MJ; Teng YH; Chen DR
Arch Pharm Res; 2010 Aug; 33(8):1181-91. PubMed ID: 20803121
[TBL] [Abstract][Full Text] [Related]
16. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
17. Quercetin as a systemic chemopreventative agent: structural and functional mechanisms.
Mendoza EE; Burd R
Mini Rev Med Chem; 2011 Dec; 11(14):1216-21. PubMed ID: 22070678
[TBL] [Abstract][Full Text] [Related]
18. Quercetin as a Novel Therapeutic Approach for Lymphoma.
Soofiyani SR; Hosseini K; Forouhandeh H; Ghasemnejad T; Tarhriz V; Asgharian P; Reiner Ž; Sharifi-Rad J; Cho WC
Oxid Med Cell Longev; 2021; 2021():3157867. PubMed ID: 34381559
[TBL] [Abstract][Full Text] [Related]
19. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.
Ward AB; Mir H; Kapur N; Gales DN; Carriere PP; Singh S
World J Surg Oncol; 2018 Jun; 16(1):108. PubMed ID: 29898731
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA targeting by quercetin in cancer treatment and chemoprotection.
Kim DH; Khan H; Ullah H; Hassan STS; Šmejkal K; Efferth T; Mahomoodally MF; Xu S; Habtemariam S; Filosa R; Lagoa R; Rengasamy KR
Pharmacol Res; 2019 Sep; 147():104346. PubMed ID: 31295570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
